AGROGENERATION (ALAGR.PA)

FR0010641449 - Common Stock

0.056  0 (-3.11%)

Fundamental Rating

1

Overall ALAGR gets a fundamental rating of 1 out of 10. We evaluated ALAGR against 57 industry peers in the Food Products industry. Both the profitability and financial health of ALAGR have multiple concerns. ALAGR is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

ALAGR had negative earnings in the past year.
ALAGR had a positive operating cash flow in the past year.
In multiple years ALAGR reported negative net income over the last 5 years.
Of the past 5 years ALAGR 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -11.44%, ALAGR is doing worse than 89.09% of the companies in the same industry.
ALAGR has a Return On Equity of -31.17%. This is amonst the worse of the industry: ALAGR underperforms 89.09% of its industry peers.
ALAGR's Return On Invested Capital of 1.99% is on the low side compared to the rest of the industry. ALAGR is outperformed by 76.36% of its industry peers.
Industry RankSector Rank
ROA -11.44%
ROE -31.17%
ROIC 1.99%
ROA(3y)-31.43%
ROA(5y)-26.1%
ROE(3y)-85.75%
ROE(5y)-69.89%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ALAGR has a worse Operating Margin (3.31%) than 61.82% of its industry peers.
ALAGR's Operating Margin has declined in the last couple of years.
ALAGR's Gross Margin of 22.23% is on the low side compared to the rest of the industry. ALAGR is outperformed by 80.00% of its industry peers.
ALAGR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.31%
PM (TTM) N/A
GM 22.23%
OM growth 3Y-19.56%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.59%
GM growth 5Y43.69%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALAGR is destroying value.
The number of shares outstanding for ALAGR remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALAGR has been increased compared to 5 years ago.
The debt/assets ratio for ALAGR has been reduced compared to a year ago.

2.2 Solvency

ALAGR has an Altman-Z score of -7.47. This is a bad value and indicates that ALAGR is not financially healthy and even has some risk of bankruptcy.
ALAGR has a worse Altman-Z score (-7.47) than 94.55% of its industry peers.
The Debt to FCF ratio of ALAGR is 11.27, which is on the high side as it means it would take ALAGR, 11.27 years of fcf income to pay off all of its debts.
ALAGR's Debt to FCF ratio of 11.27 is on the low side compared to the rest of the industry. ALAGR is outperformed by 69.09% of its industry peers.
ALAGR has a Debt/Equity ratio of 0.63. This is a neutral value indicating ALAGR is somewhat dependend on debt financing.
ALAGR has a Debt to Equity ratio of 0.63. This is comparable to the rest of the industry: ALAGR outperforms 49.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.27
Altman-Z -7.47
ROIC/WACC0.56
WACC3.57%

2.3 Liquidity

A Current Ratio of 1.08 indicates that ALAGR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.08, ALAGR is doing worse than 72.73% of the companies in the same industry.
A Quick Ratio of 0.19 indicates that ALAGR may have some problems paying its short term obligations.
ALAGR's Quick ratio of 0.19 is on the low side compared to the rest of the industry. ALAGR is outperformed by 98.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.19

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.58% over the past year.
Looking at the last year, ALAGR shows a very negative growth in Revenue. The Revenue has decreased by -12.58% in the last year.
The Revenue for ALAGR have been decreasing by -16.23% on average. This is quite bad
EPS 1Y (TTM)66.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.3%
Revenue 1Y (TTM)-12.58%
Revenue growth 3Y-24.4%
Revenue growth 5Y-16.23%
Sales Q2Q%-12.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

ALAGR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

ALAGR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALAGR is cheaper than 74.55% of the companies in the same industry.
ALAGR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ALAGR is cheaper than 76.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.36
EV/EBITDA 5.83

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALAGR!.
Industry RankSector Rank
Dividend Yield N/A

AGROGENERATION

EPA:ALAGR (1/3/2025, 7:00:00 PM)

0.056

0 (-3.11%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap12.41M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.78
P/FCF 8.36
P/OCF 5.9
P/B 1.04
P/tB 1.05
EV/EBITDA 5.83
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY11.97%
OCF(TTM)0.01
OCFY16.94%
SpS0.07
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.44%
ROE -31.17%
ROCE 2.7%
ROIC 1.99%
ROICexc 2.11%
ROICexgc 2.12%
OM 3.31%
PM (TTM) N/A
GM 22.23%
FCFM 9.37%
ROA(3y)-31.43%
ROA(5y)-26.1%
ROE(3y)-85.75%
ROE(5y)-69.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-24.2%
ROICexcg growth 5YN/A
ROICexc growth 3Y-17.64%
ROICexc growth 5YN/A
OM growth 3Y-19.56%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.59%
GM growth 5Y43.69%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.27
Debt/EBITDA 1.57
Cap/Depr 14.44%
Cap/Sales 3.89%
Interest Coverage 6.24
Cash Conversion 43.83%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 0.19
Altman-Z -7.47
F-Score5
WACC3.57%
ROIC/WACC0.56
Cap/Depr(3y)25.01%
Cap/Depr(5y)21.52%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.58%
Revenue growth 3Y-24.4%
Revenue growth 5Y-16.23%
Sales Q2Q%-12.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2520%
EBIT growth 3Y-39.18%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.07%
OCF growth 3Y-65.36%
OCF growth 5Y-47.17%